ResMed Inc. vs Trade Desk Inc — how do they compare? ResMed Inc. trades at $196 (market cap $28.81B), while Trade Desk Inc trades at $18.25 (market cap $8.76B). The key difference: ResMed Inc. is far larger — about 3.3× Trade Desk Inc's market cap, and ResMed Inc. pays a 1.21% dividend while Trade Desk Inc pays none. Which is the better fit depends on your goals.
| RMD | TTD | |
|---|---|---|
Market Cap | $28.81B | $8.76B |
Sector | Health | Technology |
52-Week High | $293.73 | $89.76 |
52-Week Low | $182.82 | $17.33 |
Enterprise Value | $27.99B | $7.78B |
Dividend Yield | 1.21% | — |
Trailing returns across standard periods
Latest headlines on both assets
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →The Trade Desk Inc is engaged in providing a technology platform for ad buyers. Through its cloud-based platform ad buyers can create, manage, and optimize data-driven digital advertising campaigns across ad formats and channels, including display, video, audio, in-app, native and social, on a multitude of devices. Its products include Data Management Platform, Cross-Device Targeting, Video Advertising, Mobile Advertising, and others.
Read more on TTD →